NEW YORK, April 23, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the "Company"), a diversified life sciences company with key assets that include active license agreements and a proprietary microbial powered fuel cell technology, has today confirmed that, in addition to the $900,000 it raised as previously disclosed in the Current Report on Form 8-K filed on April 4, 2014, the Company has raised additional capital exceeding $200,000 USD at the same terms. This private placement capital was secured at a price of 6 cents per share ("$0.06") from various institutional and accredited individual investors, which brings the total raised since March 31, 2014 to more than $1,100,000 USD all at $0.06. There were no warrants or registration rights offered in conjunction with this private placement financing and the shares issued are "restricted securities" as defined by Rule 144 of the Securities Act of 1933, as amended. This additional private placement capital has strengthened the Company's balance sheet and enabled the Company to significantly reduce its outstanding convertible debt; which as of April 23, 2014 is less than $350,000 USD.